Assessment of the role of thrombin activatable fibrinolysis inhibitor in retinal vein occlusion

---

Copy For Citation

Gumus K., Kadayifcilar S., Eldem B., Ozcebe O.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, vol.27, no.5, pp.578-583, 2007 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 27 Issue: 5
• Publication Date: 2007
• Doi Number: 10.1097/01.iae.0000256040.24444.b0
• Journal Name: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.578-583
• Hacettepe University Affiliated: Yes

Abstract

Purpose: To determine whether elevated levels of thrombin activatable fibrinolysis inhibitor (TAFI) may contribute to thrombotic risk for patients with retinal vein occlusion (RVO) and to investigate the possible correlations between TAR activity level and other conventional risk factors.